NCT/Study#
NCT05684965 /
XTX301
A First-in-Human, Multicenter, Phase 1, Open-Label Study of XTX301 in Patients With Advanced Solid Tumors
DISEASE GROUP:
Advanced Solid Tumors
current phase:
Phase I
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
